Clinical Trials

APOBEC3 Expression in HPV-Related Malignancies as a Novel Biomarker of Response to Definitive Chemoradiation

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Shraddha Dalwadi, MD, MBA

For more information about this study
View Details

About This Study

This is a non-randomized biomarker study with the aim to evaluate the relationship between APOBEC3B (A3B) expression in primary head and neck cancers (HNC), anus, and cervix tumors and pathologic response to definitive chemoradiation therapy.